4.7 Article

Hyperglycemia and gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing

Journal

FASEB JOURNAL
Volume 35, Issue 3, Pages -

Publisher

WILEY
DOI: 10.1096/fj.202000326RR

Keywords

BODIPY; cytotrophoblast; gestational diabetes; hyperglycemia; lipids; metabolism; mitochondria; mitochondrial respiration; placenta; syncytiotrophoblast

Funding

  1. NIH [5 K12 HD085809-03, 1 R21 HD090529-01, 5 F30 HD084095-04]
  2. M. Lowell Edwards Endowment

Ask authors/readers for more resources

The study revealed that maternal glycemia affects the placental metabolism of trophoblast cell types in pregnant women with gestational diabetes mellitus. It was found that the suppressed metabolic activity is mainly due to dysfunction of CTB cells, leading to decreased hormone expression and secretion.
The degree that maternal glycemia affects placental metabolism of trophoblast cell types [cytotrophoblast (CTB) and syncytiotrophoblast (SCT)] in pregnant persons with gestational diabetes mellitus (GDM) is unknown. We tested the hypotheses that (a) hyperglycemia suppresses the metabolic rates of CTB and SCT; and (b) low placental metabolic activity from GDM placentas is due to decreased oxygen consumption of CTB. Trophoblast cells isolated from GDM and non-GDM term placentas were cultured for 8-hour (CTB) and following syncytialization at 72-hour (SCT) in 5 mM of glucose or 25 mM of glucose. Oxygen consumption rates, glycolysis, ATP levels, and lipid droplet morphometries were determined in CTB and SCT. In CTB from GDM placentas compared to control CTB: (a) oxidative phosphorylation was decreased by 44% (41.8 vs 74.2 pmol O-2/min/100 ng DNA, P = .002); (b) ATP content was 39% lower (1.1 x 10(-7) vs 1.8 x 10(-7) nM/ng DNA, P = .046); and (c) lipid droplets were two times larger (31.0 vs 14.4 mu m(2)/cell, P < .001) and 1.7 times more numerous (13.5 vs 7.9 lipid droplets/cell, P < .001). Hyperglycemia suppressed CTB glycolysis by 55%-60% (mean difference 20.4 [GDM, P = .008] and 15.4 [non-GDM, P = .029] mpH/min/100 ng DNA). GDM SCT was not metabolically different from non-GDM SCT. However, GDM SCT had significantly decreased expression of genes associated with differentiation including hCG, GCM1, and syncytin-1. We conclude that suppressed metabolic activity by the GDM placenta is attributable to metabolic dysfunction of CTB, not SCT. Critical placental hormone expression and secretion are decreased in GDM trophoblasts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available